The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development—Part 2: Introduction to Pharmacokinetic Modeling Methods
Open accessAbstract
Population pharmacokinetic models are used to describe the time course of drug exposure in patients and to investigate sources of variability in patient exposure. They can be used to simulate alternative dose regimens, allowing for informed assessment of dose regimens before study conduct. This paper is the second in a three‐part series, providing an introduction into methods for developing and evaluating population pharmacokinetic models. Example model files are available in the Supplementary Data online. CPT: Pharmacometrics & Systems Pharmacology (2013) 2, e38; doi: 10.1038/psp.2013.14 ; advance online publication 17 April 2013
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kass, R. E., & Raftery, A. E. (1995) · Journal of the American Statistical Association · doi:10.1080/01621459.1995.10476572 · Cited by 12,558
McLachlan, G., & Peel, D. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/0471721182 · Cited by 10,991
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925
Efron, B., & Tibshirani, R. (1986) · Statistical Science · doi:10.1214/ss/1177013815 · Cited by 6,033
Log-normal distributions across the sciences: keys and clues
LIMPERT, E., STAHEL, W. A., & ABBT, M. (2001) · BioScience · doi:10.1641/0006-3568(2001)051[0341:lndats]2.0.co;2 · Cited by 2,621
The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves
Hill, A. V., Hill, A. L., & Hill, A. V. (1910) · The Journal of Physiology · Cited by 2,181
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., & Perelson, A. S. (1998) · Science · doi:10.1126/science.282.5386.103 · Cited by 2,113
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Bergstrand, M., Hooker, A. C., Wallin, J. E., & Karlsson, M. O. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9255-z · Cited by 1,428
Primer of Applied Regression & Analysis of Variance
Glantz, S. A., & Slinker, B. K. (1990) · UCLA - Biblioteca de Ciencias y Tecnologia Felix Morales Bueno · Cited by 1,189
Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine
Sheiner, L. B., Stanski, D. R., Vozeh, S., Miller, R. D., & Ham, J. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979253358 · Cited by 1,134
Ways to Fit a PK Model with Some Data Below the Quantification Limit
Beal, S. L. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1012299115260 · Cited by 1,114
Variance components testing in the longitudinal mixed effects model
Stram, D. O., & Lee, J. W. (1994) · Biometrics · doi:10.2307/2533455 · Cited by 992
Linear and Nonlinear Models for the Analysis of Repeated Measurements
Vonesh, E., & Chinchilli, V. M. (1996) · CRC Press eBooks · doi:10.1201/9781482293272 · Cited by 989
Comparison of four basic models of indirect pharmacodynamic responses
Dayneka, N. L., Garg, V., & Jusko, W. J. (1993) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061691 · Cited by 821
Hughes, M. A., Glass, P. S. A., & Jacobs, J. R. (1992) · Anesthesiology · doi:10.1097/00000542-199203000-00003 · Cited by 784
Measuring Skewness: A Forgotten Statistic?
Doane, D. P., & Seward, L. E. (2011) · Journal of Statistics Education · doi:10.1080/10691898.2011.11889611 · Cited by 767
Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions
Savic, R. M., & Karlsson, M. O. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9133-0 · Cited by 636
Learning versus confirming in clinical drug development*
Sheiner, L. B. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90160-0 · Cited by 633
Pharmacokinetic-Pharmacodynamic Modeling and Simulation
Bonate, P. L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9485-1 · Cited by 572
Sheiner, L. B., & Beal, S. L. (1980) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01060053 · Cited by 566
Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development
Mould, D., & Upton, R. (2012) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2012.4 · Cited by 544
Self-citationKarlsson, M. O., & Savic, R. M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100241 · Cited by 541
Model of Chemotherapy-Induced Myelosuppression With Parameter Consistency Across Drugs
Friberg, L. E., Henningsson, A., Maas, H., Nguyen, L., & Karlsson, M. O. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.140 · Cited by 534
Savic, R. M., Jonker, D. M., Kerbusch, T., & Karlsson, M. O. (2007) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-007-9066-0 · Cited by 500
The importance of modeling interoccasion variability in population pharmacokinetic analyses
Karlsson, M. O., & Sheiner, L. B. (1993) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01113502 · Cited by 485
A Size Standard for Pharmacokinetics
Holford, N. H. G. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630050-00001 · Cited by 482
Principles: Receptor theory in pharmacology
Kenakin, T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.012 · Cited by 412
Evaluating Pharmacokinetic/Pharmacodynamic Models Using the Posterior Predictive Check
Yano, Y., Beal, S. L., & Sheiner, L. B. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1011555016423 · Cited by 407
Bouillon, T. W., Bruhn, J., Radulescu, L., Andresen, C., Shafer, T. J., Cohane, C., & Shafer, S. L. (2004) · Anesthesiology · doi:10.1097/00000542-200406000-00006 · Cited by 375
Zero‐Altered and other Regression Models for Count Data with Added Zeros
Heilbron, D. C. (1994) · Biometrical Journal · doi:10.1002/bimj.4710360505 · Cited by 375
Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance
Zhang, L., Beal, S. L., & Sheiner, L. B. (2003) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/b:jopa.0000012998.04442.1f · Cited by 369
Clearance approaches in pharmacology.
Wilkinson, G. R. (1987) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06653-0 · Cited by 355
Conditional Weighted Residuals (CWRES): A Model Diagnostic for the FOCE Method
Hooker, A. C., Staatz, C. E., & Karlsson, M. O. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9361-x · Cited by 355
Handling Data Below the Limit of Quantification in Mixed Effect Models
Bergstrand, M., & Karlsson, M. O. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9112-5 · Cited by 335
Likelihood based approaches to handling data below the quantification limit using NONMEM VI
Ahn, J. E., Karlsson, M. O., Dunne, A., & Ludden, T. M. (2008) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-008-9094-4 · Cited by 328
Sheiner, L. B., & Beal, S. L. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600711209 · Cited by 302
Opioid Tolerance Development: A Pharmacokinetic/Pharmacodynamic Perspective
Dumas, E. O., & Pollack, G. M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9056-1 · Cited by 269
Sheiner, L. B. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409015063 · Cited by 257
Kinetics of pharmacologic effects in man: The anticoagulant action of warfarin
Nagashima, R., O'Reilly, R. A., & Levy, G. (1969) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196910122 · Cited by 230
Wählby, U., Jonsson, E. N., & Karlsson, M. O. (2002) · AAPS PharmSci · doi:10.1208/ps040427 · Cited by 222
Exponential Data Transformations
Manly, B. F. J. (1976) · The Statistician · doi:10.2307/2988129 · Cited by 208
The utility of modeling and simulation in drug development and regulatory review
Huang, S.-M., Abernethy, D. R., Wang, Y., Zhao, P., & Zineh, I. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23570 · Cited by 206
A PHARMACODYNAMIC MODEL FOR PANCURONIUM
HULL, C. J., BEEM, H. B. H. V., MCLEOD, K., SIBBALD, A., & WATSON, M. J. (1978) · British Journal of Anaesthesia · doi:10.1093/bja/50.11.1113 · Cited by 195
Organization of circadian functions: interaction with the body
Buijs, R. M., Scheer, F. A., Kreier, F., Yi, C., Bos, N., Goncharuk, V. D., & Kalsbeek, A. (2006) · Progress in Brain Research · doi:10.1016/s0079-6123(06)53020-1 · Cited by 188
Whole-body physiologically based pharmacokinetic models
Nestorov, I. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.2.235 · Cited by 188
Power, Selection Bias and Predictive Performance of the Population Pharmacokinetic Covariate Model
Ribbing, J., & Niclas Jonsson, E. (2004) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/b:jopa.0000034404.86036.72 · Cited by 171
On Jointly Estimating Parameters and Missing Data by Maximizing the Complete-Data Likelihood
Little, R. J. A., & Rubin, D. B. (1983) · The American Statistician · doi:10.1080/00031305.1983.10483106 · Cited by 161
The Biological Clock: The Bodyguard of Temporal Homeostasis
Perreau‐Lenz, S., Pévet, P., Buijs, R. M., & Kalsbeek, A. (2004) · Chronobiology International · doi:10.1081/cbi-120027984 · Cited by 150
Sharma, A., Ebling, W. F., & Jusko, W. J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980171q · Cited by 132
Derivation of various NONMEM estimation methods
Wang, Y. (2007) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-007-9060-6 · Cited by 131
Common noncompartmental pharmacokinetic variables: are they normally or log-normally distributed?
Lacey, L. F., Keene, O. N., Pritchard, J. F., & Bye, A. (1997) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543409708835177 · Cited by 123
Yoshida, K. J., Maeda, K., & Sugiyama, Y. (2012) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140309 · Cited by 123
Mould, D. R., Baumann, A., Kuhlmann, J., Keating, M. J., Weitman, S., Hillmen, P., Brettman, L. R., Reif, S., & Bonate, P. L. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02914.x · Cited by 116
Self-citationFundamentals of Population Pharmacokinetic Modelling
Kiang, T. K. L., Sherwin, C. M. T., Spigarelli, M. G., & Ensom, M. H. H. (2012) · Clinical Pharmacokinetics · doi:10.1007/bf03261928 · Cited by 111
Yafune, A., & Ishiguro, M. (1999) · Statistics in Medicine · Cited by 111
A Joint Model for Nonlinear Longitudinal Data with Informative Dropout
Hu, C., & Sale, M. E. (2003) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1023249510224 · Cited by 107
Mould, D. R. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.122 · Cited by 94
Self-citationDavda, J. P., & Hansen, R. J. (2010) · mAbs · doi:10.4161/mabs.2.5.12833 · Cited by 93
Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumors
Mould, D. R., Holford, N. H. G., Schellens, J. H. M., Beijnen, J. H., Hutson, P. R., Rosing, H., Huinink, W. W. T. B., Rowinsky, E. K., Schiller, J. H., Russo, M., et al. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.123553 · Cited by 87
Self-citationPillai, G. C., Gieschke, R., Goggin, T. K., Jacqmin, P., Schimmer, R. C., & Steimer, J. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02224.x · Cited by 87
Nieforth, K. A., Nadeau, R., Patel, I. H., & Mould, D. R. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90003-x · Cited by 81
Self-citationAssessment of Type I Error Rates for the Statistical Sub-model in NONMEM
Wählby, U., Bouw, M. R., Jonsson, E. N., & Karlsson, M. O. (2002) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1020254823597 · Cited by 72
Semiparametric Distributions With Estimated Shape Parameters
Petersson, K., Hanze, E., Savić, R. M., & Karlsson, M. O. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9931-1 · Cited by 70
Simultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam
Mould, D. R., DeFeo, T. M., Reele, S. B., Milla, G. M. D. M., Limjuco, R. A., Crews, T., Choma, N., & Patel, I. H. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90070-5 · Cited by 66
Self-citationReview of Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C
Wilby, K. J., Partovi, N., Ford, J., et al. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/751057 · Cited by 66
Yeo, K. R., Jamei, M., & Rostami‐Hodjegan, A. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.13.4 · Cited by 63
Krzyżański, W., Wiczling, P., Lowe, P. J., Pigeolet, E., Fink, M., Berghout, A., & Balser, S. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010376966 · Cited by 54
More efficient clinical trials through use of scientific model-based statistical tests
Jonsson, E. N. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.129307 · Cited by 51
Pharmacodynamic model of topotecan-induced time course of neutropenia.
Zamboni, W. C., D’Argenio, D. Z., Stewart, C. F., MacVittie, T., Delauter, B. J., Farese, A. M., Potter, D. M., Kubat, N. M., Tubergen, D. G., & Egorin, M. J. (2001) · PubMed · Cited by 48
Chang, C., Byon, W., Lu, Y., Jacobsen, L. K., Badura, L. L., Sawant‐Basak, A., Miller, E. L., Liu, J., Grimwood, S., Wang, E. Q., et al. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9296-3 · Cited by 45
Using Disease Progression Models as a Tool to Detect Drug Effect
Mould, D. R., Denman, N. G., & Duffull, S. B. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100228 · Cited by 44
Self-citationPharmacokinetics tricks and traps: flip-flop models.
Boxenbaum, H. (1998) · PubMed · Cited by 43
Andresen, T., Upton, R. N., Foster, D. J. R., Christrup, L. L., Arendt‐Nielsen, L., & Drewes, A. M. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00649.x · Cited by 43
Self-citationGibiansky, L. V., Gibiansky, E., & Bauer, R. J. (2011) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-011-9228-y · Cited by 43
Xu, X. S., Dunne, A., Kimko, H. H. C., Nandy, P., & Vermeulen, A. (2011) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-011-9201-9 · Cited by 39
Tunblad, K., Lindbom, L., McFadyen, L., Jonsson, E. N., Marshall, S. F., & Karlsson, M. O. (2008) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-008-9099-z · Cited by 30
Kinetics of drug action: An overview
Levy, G. (1986) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(86)90057-6 · Cited by 25
Friberg, L. E., Vermeulen, A., Petersson, K., & Karlsson, M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.234 · Cited by 25
Frame, B. C., Miller, R., & Hutmacher, M. M. (2009) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-009-9137-5 · Cited by 22
A physiologically-based recirculatory meta-model for nasal fentanyl in man
Upton, R. N., Foster, D. J. R., Christrup, L. L., Dale, O., Moksnes, K., & Popper, L. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9268-y · Cited by 14
Self-citationAnalyzing Multi-Response Data Using Forcing Functions
Zhang, L., & Sheiner, L. B. (2005) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-005-0065-8 · Cited by 4
Cited by
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics
Nguyen, T. H. T., Mouksassi, M., Holford, N., Al‐Huniti, N., Freedman, I., Hooker, A. C., John, J., Karlsson, M. O., Mould, D. R., Pérez Ruixo, J. J., et al. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12161 · Cited by 402
Self-citationMarques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., Silva, I., Magalhães, P., Schmidt, S., & Vale, N. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030332 · Cited by 390
Workgroup, E. M., Marshall, S., Burghaus, R., Cosson, V, Cheung, S., Chenel, M., DellaPasqua, O., Frey, N., Hamrén, B., Harnisch, L., et al. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12049 · Cited by 373
Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
Nielsen, E. I., & Friberg, L. E. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005769 · Cited by 332
Dotan, I., Ron, Y., Yanai, H., Becker, S., Fishman, S., Yahav, L., Ben Yehoyada, M., & Mould, D. R. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000212 · Cited by 291
Self-citation
Metadata
- Authors
- Mould, D., & Upton, R.
- Venue
- CPT: Pharmacometrics & Systems Pharmacology
- Publisher
- Wiley
- Published
- 2013-04
- Volume
- 2
- Issue
- 4
- Pages
- 1-14
- ISSN
- 2163-8306 (ISSN-L)
- OpenAlex
- W2035387023
- Cited by
- 897
- References
- 81
- FWCI
- 27.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.